Q4 2019 Matinas BioPharma Holdings Inc Earnings Call Transcript
Greetings and welcome to the Matinas BioPharma Fourth Quarter and Full Year 2019 Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to Peter Vozzo, Investor Relations Representative for Matinas BioPharma. You may begin.
Thank you, Rob. Good morning, everyone, and thank you for joining the Matinas BioPharma Fourth Quarter and Full Year 2019 Results Conference Call. Earlier this morning, we issued a press release with our fourth quarter and full year 2019 financial results, along with business updates. The release is available on the Matinas BioPharma website under the Investors section.
Speaking on today's call will be Jerry Jabbour, Chief Executive Officer; Dr. Terry Ferguson, Chief Medical Officer; Dr. Terri Matkovits, Chief Development Officer; and Keith Kucinski, Chief Financial Officer.
At this time, I would like to remind our listeners that remarks made during this call may state management's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |